- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04748497
Performance Assessement for Paralympic Athletes (PARAPERF)
March 21, 2022 updated by: Assistance Publique - Hôpitaux de Paris
Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports
The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.
The secondary objectives of the study:
- quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
- quantification and mechanical monitoring by the made-to-measure or usual sportive material.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors.
The interactions between athletes, equipment, training and environment influences the development of athletes' performance.
In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers.
Study Type
Interventional
Enrollment (Anticipated)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jean François Toussaint, MD, PhD
- Phone Number: +33 (0)1 42 34 82 10
- Email: jean-francois.toussaint@aphp.fr
Study Contact Backup
- Name: François Genêt, MD, PhD
- Phone Number: +33 (0)1.47.10.70.68
- Email: francois.genet@aphp.fr
Study Locations
-
-
-
Garches, France, 92380
- Recruiting
- Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
- Aged >= 14 years;
- Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
- Covered by social security system.
Exclusion Criteria:
- Temporary or definitive contraindication to the practice of the affected sport activity;
- Undergoing anti-coagulated treatments;
- Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
- Under guardianship or judicial decision;
- Ongoing pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Parasportives of various disciplines
|
Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic sportive activity
Time Frame: through study completion, an average of 1 year
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
through study completion, an average of 1 year
|
Dynamic sportive activity
Time Frame: at 42 months
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
at 42 months
|
Static sportive activity
Time Frame: through study completion, an average of 1 year
|
Static sportive activity: maximal speed of movement of pression center.
|
through study completion, an average of 1 year
|
Static sportive activity
Time Frame: at 42 months
|
Static sportive activity: maximal speed of movement of pression center.
|
at 42 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biomechanical indices of performance: isometric power measurement
Time Frame: through study completion, an average of 1 year
|
Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
|
through study completion, an average of 1 year
|
Biomechanical indices of performance: arms and shoulder's Strength
Time Frame: through study completion, an average of 1 year
|
Arms and shoulder's Strength will be measured by force platform.
|
through study completion, an average of 1 year
|
Physiological indices of performance: maximal aerobic speed (MAS)
Time Frame: Twice through study completion, an average of 42 months
|
Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
|
Twice through study completion, an average of 42 months
|
Physiological indices of performance: maximal aerobic power
Time Frame: Twice through study completion, an average of 42 months
|
Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
|
Twice through study completion, an average of 42 months
|
Fatigue assessment
Time Frame: Twice through study completion, an average of 42 months
|
Fatigue assessment will be measured by Fatigue Index (Power max ratio).
|
Twice through study completion, an average of 42 months
|
Blood lactate concentration
Time Frame: immediately after the intervention
|
Blood lactatemia level will be measured by lactometer.
|
immediately after the intervention
|
VO2 peak oxygen uptake
Time Frame: through study completion, an average of 1 year
|
VO2 peak oxygen uptake
|
through study completion, an average of 1 year
|
Peak breath expiration volume assessment
Time Frame: through study completion, an average of 1 year
|
VE peak: peak breath expiration volume
|
through study completion, an average of 1 year
|
Peak cardiac frequence
Time Frame: through study completion, an average of 1 year
|
CF: peak cardiac frequence
|
through study completion, an average of 1 year
|
Musculo-squeletic troubles risks measurement
Time Frame: through study completion, an average of 1 year
|
Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e.
"Constant scale").
|
through study completion, an average of 1 year
|
Time and distance of deceleration of wheelchair during riding test
Time Frame: through study completion, an average of 1 year
|
Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
|
through study completion, an average of 1 year
|
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion
Time Frame: through study completion, an average of 1 year
|
Applied forces on handrim during the propulsion: measured by force platform.
|
through study completion, an average of 1 year
|
Acceleration profil during the propulsion
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
Speed profil during the propulsion
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: François Genêt, MD, PhD, Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
- Study Director: Jean François Toussaint, MD, PhD, Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2021
Primary Completion (Anticipated)
June 1, 2024
Study Completion (Anticipated)
June 1, 2024
Study Registration Dates
First Submitted
December 11, 2020
First Submitted That Met QC Criteria
February 6, 2021
First Posted (Actual)
February 10, 2021
Study Record Updates
Last Update Posted (Actual)
March 22, 2022
Last Update Submitted That Met QC Criteria
March 21, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- APHP201139
- 2020-A02919-30 (Registry Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paralympic Athletes
-
Ankara Yildirim Beyazıt UniversityCompletedParalympic AthletesTurkey
-
PepsiCo Global R&DCompletedFluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in AthletesUnited States
-
University of BrasiliaNot yet recruiting
-
Universiti Putra MalaysiaNot yet recruiting
-
Hong Kong Metropolitan UniversityCompleted
-
São Paulo State UniversityCompleted
-
Dokuz Eylul UniversityRecruitingAthletes | VolleyballTurkey
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Istituto per la Ricerca e l'Innovazione BiomedicaCompleted
Clinical Trials on Standardization of evaluation and follow-up
-
University Hospital, BordeauxCompletedHealth Services for the AgedFrance
-
Butler HospitalNational Institute of Mental Health (NIMH)Enrolling by invitationBipolar Disorder | Substance Use DisordersUnited States
-
Helsinki University Central HospitalCompletedIntrauterine ContraceptionFinland
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
VA Office of Research and DevelopmentButler HospitalCompleted
-
Rabin Medical CenterUnknown
-
VA Office of Research and DevelopmentProvidence VA Medical CenterRecruitingBipolar Disorder | Substance Use DisordersUnited States
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Institut Claudius RegaudCompleted
-
Universitaire Ziekenhuizen KU LeuvenRecruitingPrimary Total Knee ArthroplastyBelgium